Dr. Alice Foti is a research fellow at the University of Enna “Kore”, where she is involved in the in vitro evaluation of cyclin-dependent kinase (CDK) inhibitors for the treatment of medulloblastoma, a malignant pediatric brain tumor. Her project integrates molecular oncology and drug screening to explore innovative therapeutic strategies. She holds a Master’s degree in Biomolecular Chemistry (summa cum laude) and has She earned her PhD in Chemical Sciences from the University of Catania, with a thesis on the bioinspired and green synthesis of nanoparticles for advanced wound care applications. She is also intern in Clinical Pathology and Clinical Biochemistry. Her research interests include bioactive materials, pediatric oncology, and nanotechnology-based drug delivery systems.
Dr. Alice Foti is a research fellow at the University of Enna “Kore”, where she is involved in the in vitro evaluation of cyclin-dependent kinase (CDK) inhibitors for the treatment of medulloblastoma, a malignant pediatric brain tumor. Her project integrates molecular oncology and drug screening to explore innovative therapeutic strategies. She holds a Master’s degree in Biomolecular Chemistry (summa cum laude) and has She earned her PhD in Chemical Sciences from the University of Catania, with a thesis on the bioinspired and green synthesis of nanoparticles for advanced wound care applications. She is also intern in Clinical Pathology and Clinical Biochemistry. Her research interests include bioactive materials, pediatric oncology, and nanotechnology-based drug delivery systems.